Swan Drugs India Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2013.

2013 Hyderabad, Telangana, India Struck Off

Last Updated: July 24, 2025

About Swan Drugs India Private Limited

Swan Drugs India Private Limited, a struck off private limited company, was established on 26 October 2013 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233TG2013PTC090723. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Dayakar Thota (Director), Sai Mamidi Praveen (Director), Thota Rajesh (Director). It is based at Plot No.192, H.No.1-7-138/9/1, Srinivasa Nagar Colony, Temple Alwal, Secunderabad, Hyderabad, Telangana, 500010.

Company Details

CIN/LLPIN
U24233TG2013PTC090723
Registration Number
090723
Incorporation Date
26 October 2013
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 0.10 M as on 24-07-2025
Paid Up Capital ₹ 0.10 M as on 24-07-2025
Company Age 12 Year, 4 Months

Comprehensive Company Insights

Explore comprehensive insights into Swan Drugs India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Swan Drugs India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Dayakar Thota	Director	25 Mar 2014	Current
Sai Mamidi Praveen	Director	26 Oct 2013	Current
Thota Rajesh	Director	25 Mar 2014	Current
Amballa Anil Kumar	Director	26 Oct 2013	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Swan Drugs India.

Enhance accessibility to Swan Drugs India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Swan Drugs India?

Unlock access to Swan Drugs India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Swan Drugs India?

Unlock and access historical data on people associated with Swan Drugs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Swan Drugs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swan Drugs India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Swan Drugs India

Recent Activity within the Organization

Director Appointment

Dayakar Thota was appointed as a Director was appointed as a Director on 25 Mar 2014 & has been associated with this company since 11 years 11 months . was recorded as a recent event.
25 Mar 2014
Director Appointment

Progress on Thota Rajesh was appointed as a Director was appointed as a Director on 25 Mar 2014 & has been associated with this company since 11 years 11 months . was documented.
25 Mar 2014
Director Appointment

Progress on Sai Mamidi Praveen was appointed as a Director was appointed as a Director on 26 Oct 2013 & has been associated with this company since 12 years 4 months . was documented.
26 Oct 2013
Director Appointment

Amballa Anil Kumar was appointed as a Director was appointed as a Director on 26 Oct 2013 & has been associated with this company since 12 years 4 months . was recorded as a recent event.
26 Oct 2013
Company Incorporation

Progress on Swan Drugs India Private Limited was registered on 26 Oct 2013 with Roc Hyderabad & aged 12 years 4 months as per MCA records. was documented.
26 Oct 2013

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Swan Drugs India Private Limited?

The CIN of Swan Drugs India Private Limited is U24233TG2013PTC090723.

Where is Swan Drugs India Private Limited headquartered?

Swan Drugs India Private Limited is headquartered at Plot No.192, H.No.1-7-138/9/1, Srinivasa Nagar Colony, Temple Alwal, Secunderabad, Hyderabad, Telangana, 500010.

When was Swan Drugs India Private Limited incorporated?

Swan Drugs India Private Limited was incorporated on 26 October 2013.

Who are the current directors of Swan Drugs India Private Limited?

The current directors of Swan Drugs India Private Limited are

What is the primary industry of Swan Drugs India Private Limited?

The primary industry of Swan Drugs India Private Limited is Chemicals.

Is Swan Drugs India Private Limited a listed company?

Swan Drugs India Private Limited is unlisted.

What is the capital structure of Swan Drugs India Private Limited?

The authorized capital of Swan Drugs India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available